Cargando…
How to mathematically optimize drug regimens using optimal control
This article gives an overview of a technique called optimal control, which is used to optimize real-world quantities represented by mathematical models. I include background information about the historical development of the technique and applications in a variety of fields. The main focus here is...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5847021/ https://www.ncbi.nlm.nih.gov/pubmed/29411198 http://dx.doi.org/10.1007/s10928-018-9568-y |
_version_ | 1783305670064340992 |
---|---|
author | Moore, Helen |
author_facet | Moore, Helen |
author_sort | Moore, Helen |
collection | PubMed |
description | This article gives an overview of a technique called optimal control, which is used to optimize real-world quantities represented by mathematical models. I include background information about the historical development of the technique and applications in a variety of fields. The main focus here is the application to diseases and therapies, particularly the optimization of combination therapies, and I highlight several such examples. I also describe the basic theory of optimal control, and illustrate each of the steps with an example that optimizes the doses in a combination regimen for leukemia. References are provided for more complex cases. The article is aimed at modelers working in drug development, who have not used optimal control previously. My goal is to make this technique more accessible in the biopharma community. |
format | Online Article Text |
id | pubmed-5847021 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-58470212018-03-20 How to mathematically optimize drug regimens using optimal control Moore, Helen J Pharmacokinet Pharmacodyn Original Paper This article gives an overview of a technique called optimal control, which is used to optimize real-world quantities represented by mathematical models. I include background information about the historical development of the technique and applications in a variety of fields. The main focus here is the application to diseases and therapies, particularly the optimization of combination therapies, and I highlight several such examples. I also describe the basic theory of optimal control, and illustrate each of the steps with an example that optimizes the doses in a combination regimen for leukemia. References are provided for more complex cases. The article is aimed at modelers working in drug development, who have not used optimal control previously. My goal is to make this technique more accessible in the biopharma community. Springer US 2018-02-06 2018 /pmc/articles/PMC5847021/ /pubmed/29411198 http://dx.doi.org/10.1007/s10928-018-9568-y Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Paper Moore, Helen How to mathematically optimize drug regimens using optimal control |
title | How to mathematically optimize drug regimens using optimal control |
title_full | How to mathematically optimize drug regimens using optimal control |
title_fullStr | How to mathematically optimize drug regimens using optimal control |
title_full_unstemmed | How to mathematically optimize drug regimens using optimal control |
title_short | How to mathematically optimize drug regimens using optimal control |
title_sort | how to mathematically optimize drug regimens using optimal control |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5847021/ https://www.ncbi.nlm.nih.gov/pubmed/29411198 http://dx.doi.org/10.1007/s10928-018-9568-y |
work_keys_str_mv | AT moorehelen howtomathematicallyoptimizedrugregimensusingoptimalcontrol |